NMS logo

Nuveen Minnesota Quality Municipal Income Fund (NMS)

$11.98

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NMS

AUM

$69328943

P/E ratio

--

Dividend yield

7.187%

Expense ratio

0.35%

Beta

0.486722

Price on NMS

Previous close

$11.95

Today's open

$11.95

Day's range

$11.92 - $12

52 week range

$11.07 - $13.10

Profile about NMS

show more

Headquarters

US

Exchange

New York Stock Exchange

Issue type

Common Stock

NMS industries and sectors

Bonds

Domestic

Municipal

News on NMS

NMS: Nuveen's Minnesota Municipal Bond CEF Rates A Sell, Here's An Alternative

A well-run single-state municipal bond fund benefits investors who pay taxes to that state.  Here I examine Nuveen Minnesota Quality Municipal Income Fund directed at Minnesota taxpayers. Along with my analysis of NMS, its performance relative to a national municipal bond CEF is provided to help judge the worthiness of state funds over a national fund. With the goal to provide higher cash flows and support secondary market trading, Nuveen increased payouts on many funds to close discounts and enhance shareholder returns.

news source

Seeking Alpha • Apr 10, 2025

news preview

Nuveen Closed-End Funds Declare Distributions

NEW YORK--(BUSINESS WIRE)--Several Nuveen closed-end funds have declared distributions. These funds represent investment strategies for investors seeking diversified sources of cash flow to prepare for and sustain their retirement income needs. For further information regarding fund distributions, including earnings, undistributed net investment income, and notices, please visit www.nuveen.com/cef. Additionally, several funds have announced distribution increases of up to 71%. The distribution.

news source

Business Wire • Jun 3, 2024

news preview

Otsuka and Lundbeck Present Results from Three Clinical Trials of Brexpiprazole in Combination with Sertraline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) today presented results from the Phase II (Trial 061) and Phase III trials (Trial 071 and 072) evaluating the safety and efficacy of brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD).1,2 The findings were presented at the American Society of Clinical Psychopharmac.

news source

Business Wire • May 28, 2024

news preview

Nuveen Closed-End Funds Declare Distributions and Updates to Distribution Policies

NEW YORK--(BUSINESS WIRE)--Nuveen Closed-End Funds today announced that the Board of Trustees of the Funds has approved the regular monthly and quarterly distributions. In addition, the Board of Trustees has approved updated distribution polices described below under “Monthly & Quarterly Distributions” for The Nuveen Preferred & Income Opportunities Fund (NYSE: JPC), Nuveen Preferred and Income Term Fund (NYSE: JPI), Nuveen Variable Rate Preferred & Income Fund (NYSE: NPFD), Nuveen.

news source

Business Wire • Dec 1, 2023

news preview

Nuveen Municipal Closed-End Funds Announce Distribution Updates

NEW YORK--(BUSINESS WIRE)--Today, the Board of Trustees of certain Nuveen municipal closed-end funds declared regular monthly distribution rates and updated certain distribution policies. Additionally, several leveraged municipal closed-end funds have announced distribution rate increases of between 7% and 24% to deliver higher monthly cash flows to shareholders. These changes are intended to help support secondary market trading in fund shares and improve each fund's discount to NAV. It is ant.

news source

Business Wire • Oct 23, 2023

news preview

¹ Disclosures

Get started with M1

Invest in Nuveen Minnesota Quality Municipal Income Fund

Open an M1 investment account to buy and sell Nuveen Minnesota Quality Municipal Income Fund commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NMS on M1